Patient‐derived organoids as a preclinical platform for precision medicine in colorectal cancer

Patient‐derived organoids are being considered as models that can help guide personalized therapy through in vitro anticancer drug response evaluation. However, attempts to quantify in vitro drug responses in organoids and compare them with responses in matched patients remain inadequate. In this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Young‐Won, Min, Dong‐Wook, Kim, Hwang‐Phill, An, Yohan, Kim, Sheehyun, Youk, Jeonghwan, Chun, Jaeyoung, Im, Jong Pil, Song, Sang‐Hyun, Ju, Young Seok, Han, Sae‐Won, Park, Kyu Joo, Kim, Tae‐You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208081/
https://www.ncbi.nlm.nih.gov/pubmed/34850547
http://dx.doi.org/10.1002/1878-0261.13144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208081/
https://www.ncbi.nlm.nih.gov/pubmed/34850547
http://dx.doi.org/10.1002/1878-0261.13144

Ejemplares similares